Podimetrics Pitch Deck: All 12 Slides + Teardown

Podimetrics, a healthcare technology company focused on preventing diabetic amputations, raised $45M in 2023 with a deck that prioritizes clinical outcomes and economic impact over technical jargon. The deck effectively frames the problem as a 'cyclic loop' of high-cost healthcare utilization, then positions its SmartMat technology as the intervention that breaks this cycle. By citing a 70% reduction in amputations and a 33% reduction in total cost of care, Podimetrics speaks directly to the incentives of its primary customers: large health plans and integrated delivery networks. While the de…

Key takeaways

• The deck leads with traction, noting revenue has doubled YoY since 2018 on Slide 2.
• Economic impact is quantified early, stating a single amputation can cost $100,000 on Slide 3.
• Clinical validation is a core pillar, citing three randomized clinical trials on Slide 6.
• The company demonstrates strong payor adoption, listing a 'Top 5 National Health Plan' and a 'Top 5 Blues Plan' as clients on Slide 2.
• Patient engagement is treated as a primary metric, reporting 70% engagement at one year on Slide 8.
• The business model is flexible, utilizing both bundled payments in the VA and PEMPM/risk-based models for private payors as shown on Slide 10.
• Intellectual property is highlighted as a competitive barrier, with four secured patents and five in progress on Slide 10.
• The deck lacks a specific 'Ask' slide detailing how the $45M will be deployed.

Frequently asked questions

What is the primary value proposition of Podimetrics?

The primary value proposition is the prevention of diabetic amputations through early detection. According to Slide 2, the company achieves a 70% reduction in amputations. This translates to significant cost savings for payors, as Slide 3 notes a single amputation costs $100,000, and Slide 8 claims a 33% reduction in the total cost of care for monitored patients.

How does the technology actually work according to the deck?

Slide 6 describes a three-part solution: evidence-based temperature monitoring, the 'SmartMat' technology, and relationship-based virtual care support. The mat is an FDA-cleared, once-daily at-home monitoring device that identifies inflammation (via heat sensing) before it becomes a Diabetic Foot Ulcer (DFU), allowing for low-cost clinical triage.

What kind of market traction has Podimetrics achieved?

Slide 2 indicates the company has been commercially available since 2017 and has doubled revenue year-over-year since 2018. Their client base includes the largest integrated healthcare system in the US, a Top 5 National Health Plan, and a Top 5 Blues Plan, with over 20 additional plans in the pipeline.

What are the competitive barriers mentioned in the deck?

Slide 10 outlines six competitive barriers: four secured patents (with five more pending), 8 years of peer-reviewed data across 7 publications, unrivaled in-market performance, a novel pricing model (PEMPM and risk-based), a pipeline of significant contracts, and a strategic advisory board across enterprise and government sectors.

Is there a clear exit strategy or financial forecast in the deck?

No. The provided slides focus on clinical efficacy, market fit, and historical growth. There are no detailed financial projections, specific exit targets (like an IPO or acquisition), or a breakdown of how the Series C funds will be spent. This is common in later-stage decks where the focus shifts to scaling a proven model.

Podimetrics pitch deck: the facts

Company

Podimetrics

Year

2023

Stage

Series C

Slides

12

Sector

Healthcare / MedTech

Deck type

Investor Pitch Deck

Outcome

$45M Raised

Headquarters

North America

Podimetrics pitch deck PDF

The full Podimetrics deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Podimetrics pitch deck was used for

This deck is Podimetrics’ Series C fundraising presentation used to secure a $45 million round announced in March 2022, focused on preventing diabetic amputations in high‑risk patients with diabetes through remote temperature monitoring and virtual care services.[1][2][3] The company’s solution centers on its FDA‑cleared SmartMat, which patients stand on daily so Podimetrics’ care team can detect early warning signs of diabetic foot complications weeks before they present clinically.[1][10][12] The deck reportedly emphasizes the economic burden of diabetic amputations and demonstrates cost savings and clinical impact achieved with SmartMat in populations such as Veterans Health Administration patients.[2][10][12] It serves as a growth-stage, Series C narrative for expanding distribution with payers and at‑risk providers and scaling workforce and services.[1][2][3][4][8]

Business model: Podimetrics is a virtual care management company that partners with payers and at‑risk providers to prevent costly and deadly diabetic amputations using its FDA‑cleared SmartMat remote temperature‑monitoring device plus integrated clinical care services.[1][10][12]

Round

Series C.[1][2][3][6][7][14]

Raised

$45 million Series C.[1][2][3][6][7][14]

Lead investor

D1 Capital Partners.[1][2][3][4][5][7][14]

Investors

D1 Capital Partners (lead)., Medtech Convergence Fund (also referenced as MedTech Venture Partners in some sources)., Polaris Partners., Scientific Health Development., Undisclosed strategic investor.

Headquarters

Somerville, Massachusetts, USA.[1]

Year: 2022.[1][2][3][6][7][14]

Industry: Healthcare / MedTech; digital health focused on diabetic foot complications and remote monitoring.[1][3][10][12]

Total funding: Podimetrics reports raising more than $73 million in total funding, including its $45 million Series C in March 2022 and prior rounds totaling about $28.3 million plus additional Series B-2 funding.[1][8]

Use of funds as presented: Podimetrics indicated it would use the Series C proceeds to hire and expand product development and research teams, grow its nurse support and clinical care services workforce, and broaden distribution of SmartMat and its remote temperature monitoring program to more homes and high‑risk patients served by at‑risk providers and health plans.[1][4][5][8][9]

What happened after the Podimetrics deck

As of the most recent publicly available information, Podimetrics successfully completed its $45 million Series C in March 2022 and has continued operating as a private company focused on scaling SmartMat distribution and its virtual care management services with health plans and at‑risk providers; no subsequent exit transaction (such as an IPO or acquisition) has been reported in the sources revi

• Announcement of a $45 million Series C round led by D1 Capital Partners with participation from Medtech Convergence Fund
• Stated plans to expand product development and research teams, as well as nurse support and clinical services, using Ser
• Public reporting of strong prior growth (e.g., 300% growth in 2020) and expanded Series B‑2 funding to support SmartMat

What the Podimetrics deck got right

• Sharp focus on a specific, costly clinical problem and its economic burden. Podimetrics’ deck and public messaging focus on a **clear, high‑cost clinical problem**—diabetic foot ulcers and amputations—and quantifies the economic burden, aligning the company’s value proposition directly with cost savings and better outcomes for high‑risk diabetic patients.[2][3][4][10][12] This problem‑centric framing is compelling for payers and investors.
• Strong clinical validation for SmartMat‑based remote monitoring. The SmartMat program is backed by **clinical evidence** showing that once‑daily remote foot temperature monitoring with Podimetrics can eliminate major diabetic amputations and reduce hospital admissions and resource utilization in high‑risk patients.[12] This evidence base strengthens the credibility of the deck’s claims about impact and savings.
• Integrated device-plus-care-management offering. Podimetrics combines an FDA‑cleared hardware device (SmartMat) with continuous data monitoring and a nurse‑led care management team, offering a **bundled solution** rather than a standalone device or app.[1][10][12][15] This integrated model is attractive to payers and at‑risk providers who need turnkey programs for complex chronic populations.
• Credible traction with major payers and at‑risk providers. The company has secured partnerships with major organizations such as the Veterans Health Administration and Independence Blue Cross, demonstrating **real‑world traction and distribution channels** with high‑risk, often underserved populations.[10] These relationships likely feature prominently in the deck as proof of scalability and payer adoption.
• High‑quality investor syndicate validating the opportunity. The Series C was led by a well‑known institutional investor, D1 Capital Partners, alongside sector‑focused and strategic investors, providing a strong **signal of investor confidence** and validation of Podimetrics’ approach and market potential.[1][2][3][4][5][14]
• Compelling health equity and impact narrative. Podimetrics positions its solution within a **health equity and disparities** narrative, emphasizing that high‑risk diabetic patients, often in underserved communities, stand to benefit from reduced amputations and improved outcomes.[1][8][12][15] This framing adds societal impact to the economic and clinical story and can resonate strongly with many investors.

What could have been stronger

• Limited visibility into detailed unit economics and payor‑specific profitability. Public information about the deck indicates a strong emphasis on total addressable cost burden and macro savings from avoiding amputations, but it is unclear whether the deck provided granular unit economics (e.g., per‑patient margins, payor‑specific pricing, detailed cohort‑level LTV/CAC) beyond broad statements about reducing overall resource utilization.[2][4][8][12] For an investor library, this makes it harder to assess the sustainability of Podimetrics’ business model from the deck alone.
• Potential under‑emphasis on operational and implementation risk in remote monitoring. The deck is reported to focus heavily on the economic burden of diabetic amputations and Podimetrics’ ability to reduce costs through remote monitoring, but external sources emphasize complex clinical populations and operational intensity (daily monitoring, nurse outreach, behavior change).[2][10][12][15] Without seeing the full text, it is unclear whether the deck robustly addressed implementation challenges and operational risk (adherence, provider workflow integration, data overload), which are material concerns for investors in remote monitoring businesses.
• Sparse detail on competitive landscape and long‑term strategic moat. Podimetrics’ Series C story is compelling in terms of clinical impact and health equity, but public information centers on clinical outcomes and cost savings, with limited concrete detail about revenue scalability across different payer segments, competitive landscape against other diabetic remote monitoring tools, or defensibility beyond SmartMat’s FDA clearance and data.[1][2][3][8][10][12][15] If the deck followed this pattern, it may not have fully explored competitive dynamics and long‑term strategic positioning.

How an investor would read this deck

What draws attention

• Evidence that SmartMat‑based remote temperature monitoring can **eliminate major amputations** and reduce hospitalizations and resource utilization in diabetic foot ulcer populations, including Kaiser Permanente research results cited by Podimetrics.[12]
• The massive **economic burden of diabetic amputations** and related hospitalizations, positioning Podimetrics as a cost‑saving, outcomes‑improving solution for high‑risk diabetic patients.[2][3][4][10][12]
• Traction with large, credible partners such as the **Veterans Health Administration** and **Independence Blue Cross**, indicating real‑world adoption in at‑risk and payer environments.[10]
• Series C led by **D1 Capital Partners** with strong syndicate including Medtech Convergence Fund, Polaris Partners, Scientific Health Development, and a strategic investor, which signals institutional confidence in Podimetrics’ model.[1][2][3][4][5][14]
• Podimetrics’ positioning around **health equity**, reduction of disparities in diabetic foot care, and focus on high‑risk, complex patients where the impact and savings may be largest.[1][8][12][15]

Risks that stand out

• Operational complexity of maintaining daily engagement and adherence among high‑risk diabetic patients, which could dilute real‑world effectiveness and cost savings relative to clinical studies if not well managed.[10][12][15]
• Dependence on payer and at‑risk provider contracts for revenue, exposing growth to changes in reimbursement, value‑based incentives, and budget cycles for digital health and remote monitoring.[1][3][4][8][10]
• Need to scale a labor‑intensive clinical operations team (nurse support, monitoring, outreach) while preserving outcomes and unit economics, which can be challenging for virtual care management companies at growth stage.[1][4][5][8]
• Competition from other remote monitoring and diabetic foot care solutions, including alternative thermometry devices and broader chronic‑care platforms that may bundle diabetic programs, potentially pressuring pricing or share if Podimetrics’ differentiation is not clear.[10][12][15]

Questions this deck invites

• How do Podimetrics’ per‑patient economics (pricing to payers, gross margin, care team cost, device cost) vary across different payer contracts (Medicare Advantage, Medicaid managed care, commercial, VA), and what is the blended margin profi
• What are real‑world adherence rates to daily SmartMat use over 12–24 months, and how does adherence impact clinical outcomes, cost savings, and churn for different patient cohorts?
• How scalable is the nurse support and care management model—what staffing ratios, automation, and clinical protocols are required to maintain quality while doubling or tripling patient volume?
• What reimbursement and contractual structures (risk‑sharing, per‑member‑per‑month, episode‑based) underpin Podimetrics’ revenue, and how exposed is growth to regulatory or payer policy changes in remote monitoring and value‑based care?
• What differentiation does Podimetrics have versus other diabetic foot monitoring or remote patient monitoring solutions (IP around thermometry, longitudinal data, FDA approvals, workflow integration), and how defensible is that moat over 5–

What founders can take from the Podimetrics deck

• A growth‑stage healthcare/MedTech deck can be highly compelling when it anchors the story in a **specific, costly clinical problem** (diabetic amputations) and quantifies both human and economic impact, rather than presenting remote monitoring in generic terms.[2][3][4][10][12]
• Demonstrating **clinical validation** (e.g., studies showing elimination of major amputations and reduced hospitalizations) materially strengthens the narrative for remote monitoring technologies and helps move the discussion from promise to proven outcomes.[12]
• Showcasing partnerships with large, credible organizations (Veterans Health Administration, major health plans) can serve as powerful **traction and distribution proof points** for enterprise‑focused digital health companies.[10]
• Clearly articulating the **use of funds**—in this case, expanding product development, research, and clinical services capacity—helps investors connect capital deployment to scaling of both technology and operations.[1][4][5][8]
• Positioning the solution within a **health equity and disparities** framework can resonate with investors and payers when the target population is high‑risk and underserved, provided that the deck ties this framing to measurable outcomes.[1][8][12][15]
• Integrating device, software, and care management into a single offering, as Podimetrics does with SmartMat plus clinical services, illustrates how **bundled solutions** can address complex chronic conditions more effectively than standalone hardware or software alone.[1][10][12]

Podimetrics pitch deck: common questions

What does Podimetrics do?

Podimetrics is a virtual care management and digital health company that uses remote daily foot temperature monitoring with its FDA‑cleared SmartMat and integrated clinical care services to help prevent diabetic foot ulcers and amputations in high‑risk patients.[1][10][12] It partners with payers and at‑risk providers, including organizations like the Veterans Health Administration and Independence Blue Cross, to deploy SmartMat and monitoring programs to eligible patients.[10]

How much did Podimetrics raise with the pitch deck, and in what round?

Podimetrics raised a **$45 million Series C** round announced March 24–25, 2022.[1][3][6][7][14] The deck highlighted in the Business Insider article was used to secure this Series C financing.[2]

Who invested in Podimetrics’ $45 million Series C round?

The $45 million Series C was **led by D1 Capital Partners**, with participation from new investors the **Medtech Convergence Fund** (also described as MedTech Venture Partners in some reports) and an undisclosed strategic investor, plus existing investors **Polaris Partners** and **Scientific Health Development**.[1][2][3][4][5][14]

What were the main uses of funds for Podimetrics’ Series C raise?

Podimetrics stated it would use the Series C capital to expand its product development and research teams, grow the nurse support and clinical services workforce, and scale distribution of the SmartMat and associated remote care services to more homes and high‑risk patients, including at‑risk providers and health plans.[1][4][5][8][9]

How does Podimetrics’ SmartMat and remote monitoring program work?

Podimetrics’ SmartMat is a cellular‑connected, FDA‑cleared foot temperature monitoring device used once daily for about 20 seconds.[1][10][12][15] Data are transmitted to Podimetrics’ care management team, which looks for early signs of inflammation that can precede diabetic foot ulcers and amputations by weeks; simple interventions (like reduced walking) can then be recommended to prevent complications and avoid hospitalizations and major amputations.[10][12][15]

Sources

Funding and outcome facts on this page were researched on 2026-08-30 from the pages below.

• Podimetrics Series C - $45M to help prevent diabetic amputations
• See the Presentation Podimetrics Used to Land $45 Million Series C
• Podimetrics raises $45M to address diabetic amputations - Axios
• Podimetrics Scores $45M in Series C Round
• Podimetrics Raises $45 Million in Series C Financing
• news
• Podimetrics - Company Profile & Funding Data - Raising.fi
• Podimetrics Stock for Accredited Investors | Pre-IPO Shares | UpMarket

Related fundraising guides (24)

• Chattermill Pitch Deck Teardown: A Masterclass in Enterprise Social Proof and Expansion Strategy
• Covey Pitch Deck Teardown: Decentralizing Asset Management via Immutable Track Records
• Empion Pitch Deck Teardown: A Culture-First Approach to Automated Recruitment
• FX HedgePool Pitch Deck Teardown: Disintermediating the $66 Trillion FX Swap Market
• Heura Pitch Deck Teardown: Dominating the Mediterranean Plant-Based Market
• Include Pitch Deck Teardown: Scaling Smart City Infrastructure Through Global Distribution
• Yuzu Health Pitch Deck Teardown: A Masterclass in Market Education and Infrastructure Replacement
• Limetree Pitch Deck Teardown: A Case Study in Early-Stage Family Media Preservation
• Agave Games Pitch Deck Teardown: A $7M Seed Round Built on Mobile Gaming Pedigree
• Arist Pitch Deck Teardown: The $12M Series A Memo Strategy for Micro-Learning
• Brag House Pitch Deck Teardown: Targeting the Casual Collegiate Esports Market
• Circ Pitch Deck Teardown: Solving the Polycotton Recycling Gap with Hydrothermal Tech
• Craft.io Pitch Deck Teardown: A $8M Series A Masterclass in Product-Led Narrative
• EnergyX Pitch Deck Teardown: A Masterclass in Industrial Validation and Scientific Pedigree
• Goldcast Pitch Deck Teardown: Turning Virtual Events Into A High-Velocity B2B Revenue Engine
• HiBob Pitch Deck Teardown: A Narrative-Driven $150M Series D Masterclass
• IRLY Pitch Deck Teardown: A Gen-Z Dating Playbook Built on Video-First Interaction
• Yelp Pitch Deck Teardown: A Post-IPO Growth Story Focused on Local Ad Dominance
• Connected Analytics Pitch Deck Teardown: Solving the Cash-Loyalty Gap in Africa
• AgBiome Pitch Deck Teardown: A $116M Series D Masterclass in Platform Validation
• Arize AI Pitch Deck Teardown: A Masterclass in Category Creation and Market Timing
• Bloom Community Pitch Deck Teardown: Scaling Niche Social Networks Through Event Flywheels
• Checkstep Pitch Deck Teardown: A 7-Slide Product Showcase for AI Content Moderation
• Dalan Animal Health Pitch Deck Teardown: A $3.5M Seed for the First Honeybee Vaccine

Decks from the same year (1)

• 2023 pitch deck examples

Decks with a similar raise (1)

• Pitch decks that raised $10M to $50M

Browse companies alphabetically (1)

• Pitch decks from companies starting with P

More pitch deck teardowns (16)

• Pluntz Pitch Deck Teardown: A Niche EDM Streaming Play from the Early Mobile Era
• Pluralsight Acquisition Pitch Deck Breakdown: Defending a $3.5B Take-Private Transaction
• PlusPlus Pitch Deck Breakdown: A Product-First Narrative for Enterprise Knowledge Sharing
• Pluto AI Pitch Deck Teardown: A Lean Demo Day Approach to Industrial Water Analytics
• Optimity Pitch Deck Breakdown: Using Engagement Metrics to Disrupt Corporate Wellness
• Ply Gem Pitch Deck Teardown: A Deep Dive into Industrial Manufacturing Financials
• Pocket Concierge Pitch Deck Teardown: Solving High-End Dining Friction for Global Travelers
• Poctor Pitch Deck Teardown: A 2016 Look at HIPAA-Compliant Network Infrastructure
• Podozi Pitch Deck Breakdown: A Minimalist Approach to African Beauty E-commerce
• Podvertise.fm Pitch Deck Teardown: A Marketplace Play for Long-Tail Podcast Ads
• Podvertise.fm Pitch Deck Teardown: A Marketplace Play for Podcast Ad Aggregation
• Podvertise.fm Pitch Deck Teardown: A Marketplace Play for SMB Podcast Advertising
• PointCatcher Pitch Deck Teardown: Targeting the $60B Loyalty Gap in B2B and SMB
• point.me Pitch Deck Teardown: Solving the $16 Billion Unredeemed Points Problem
• Polar Pants Pitch Deck Teardown: A Direct-to-Consumer Play for Insulated Formalwear
• Pollitrace Pitch Deck Teardown: A Hardware-Enabled AI Play for Global Pollination Intelligence

Recently published pitch deck teardowns (11)

• PREIT Pitch Deck Teardown: Navigating the Retail Apocalypse Through Asset Rationalization
• PRAGATI Pitch Deck Teardown: A Conceptual Framework for Blockchain-Based P2P Lending
• Altum Pitch Deck Teardown: A State-Backed Debt Issuance for Economic Development
• The shoppingpro Pitch Deck Teardown: A Browser-First Approach to E-commerce Intelligence
• TouchSpin Gaming Pitch Deck Teardown: A Social Casino Play Focused on Monetization Mechanics
• Trans Code Therapeutics Pitch Deck Teardown: Solving the RNA Delivery Challenge in Oncology
• TranslateKarate Pitch Deck Teardown: A Minimalist Approach to Localization Workflow
• Travacco Pitch Deck Teardown: Targeting Emerging Market Travel Agencies with Niche ERP
• Trip Plus Pitch Deck Teardown: Monetizing the Gap Between Price and Points
• Tutoring Pitch Deck Teardown: Scaling On-Demand Language Learning in South Korea
• Monotype Pitch Deck Teardown: Transitioning from Print to Digital Brand Engagement

Fundraising library · Pitch deck examples · Investor directory · Founder database